Press release
microRNA Industry Poised for Rapid Expansion, Forecasted CAGR of 29.4% from 2023 to 2033 - Analysis by TMR
MicroRNA Market
Explore the highlights and essential data from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1515
Market Overview
The global microRNA market has seen a significant rise in demand, driven by the need for advanced diagnostic tools and targeted therapies. In 2023, the global sales of the microRNA market stood at US$ 1.2 billion. Due to the increasing adoption of microRNA-based technologies in research and clinical applications, the market is expected to grow at a CAGR of 29.4% from 2023 to 2033, reaching an estimated value of US$ 15.5 billion by 2033. Key factors propelling market growth include advancements in proteomics and genomics, increased clinical trials, and the rising prevalence of chronic diseases.
Market Size and Growth
Between 2018 and 2022, the microRNA market experienced a compound annual growth rate (CAGR) of approximately 24.6%. This robust growth was primarily driven by increased research funding, rising biotech startups, and the development of innovative microRNA-based therapies. From 2023 to 2033, the market is expected to accelerate further, fueled by the growing acceptance of microRNA in clinical and preclinical research. The consumables segment is projected to be the highest revenue-generating category, with an anticipated CAGR of over 28.5% during the forecast period.
Competitive Landscape
The microRNA market is highly competitive, with key players focusing on technological advancements, strategic partnerships, and product innovations to gain a competitive edge. Major companies operating in the market include Thermo Fisher Scientific Inc., Miltenyi Biotec, and NanoString. These players are investing heavily in research and development to enhance their microRNA profiling technologies and expand their product portfolios. Additionally, companies are emphasizing inorganic growth strategies, such as mergers and acquisitions, to strengthen their market presence, particularly in developing regions.
Discover valuable insights and findings from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1515
Market Segmentation
The microRNA market is segmented based on services, products, applications, and end-users:
By Services: Includes isolation & purification, cDNA synthesis, profiling, localization & quantification, and functional analysis.
By Products: Comprises instruments and consumables, with consumables leading the segment due to their frequent replacement needs.
By Application: Encompasses cancer, infectious diseases, immunological disorders, cardiovascular diseases, neurological diseases, and others.
By End-Use: Covers biotechnology & pharmaceutical companies, academic & government research institutes, and other sectors.
Regional Analysis
North America: In 2022, North America accounted for the largest share of the microRNA market, driven by an increasing number of clinical trials and high healthcare spending in the United States. The U.S. market is projected to reach a valuation of US$ 6.7 billion by 2033.
Asia Pacific: This region is expected to witness the fastest growth due to a larger patient pool, rising adoption of microRNA-based treatments, and expanding medical research in countries like China, India, and Singapore.
Europe: The U.K. microRNA market is anticipated to reach US$ 440 million by 2033, with a significant absolute dollar opportunity.
Rest of the World: Increasing healthcare expenditure and technological advancements in the Middle East, Latin America, and Africa contribute to market growth in these regions.
Future Outlook
The future of the microRNA market looks promising, with ongoing research, clinical trials, and technological innovations driving its expansion. The rising number of pharma and biotech firms investing in microRNA-based therapeutics is expected to create lucrative opportunities for market players. However, challenges such as safety concerns and regulatory hurdles could hinder market growth. Despite these obstacles, advancements in RNA sequencing, biomarker discovery, and personalized medicine will likely continue to propel the microRNA market forward, making it a crucial component of modern healthcare and diagnostics.
Buy this Premium Research Report to access comprehensive analysis - https://www.transparencymarketresearch.com/checkout.php?rep_id=1515<ype=S
More Trending Reports by Transparency Market Research -
Animal Genetics Market: https://www.transparencymarketresearch.com/animal-genetics-market.html
Coagulation Testing Market: https://www.transparencymarketresearch.com/coagulation-testing-market.html
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release microRNA Industry Poised for Rapid Expansion, Forecasted CAGR of 29.4% from 2023 to 2033 - Analysis by TMR here
News-ID: 3905917 • Views: …
More Releases from Transparency Market Research
Medium Voltage Fuse Market Outlook 2031: Global Market to Reach US$ 1.8 Billion …
The global medium voltage fuse market is steadily transitioning from a traditional grid-protection niche to a strategic enabler of modern power systems. Rising investments in renewable energy integration, large-scale electrification programs, and infrastructure upgrades are reshaping demand patterns worldwide. Medium voltage fuses-typically rated between 1 kV and 35 kV-are no longer viewed as passive safety components; instead, they are increasingly recognized as critical assets for grid stability, asset protection, and…
Lamination Films Market Outlook 2032: Global Industry Size to Surpass US$ 12.21 …
The global lamination films market was valued at US$ 8,123.4 million in 2023 and is forecast to reach US$ 8,514.1 million in 2024. Over the forecast period from 2024 to 2032, the market is projected to expand at a compound annual growth rate (CAGR) of 4.6%, ultimately exceeding US$ 12,213.1 million by 2032. This steady growth trajectory reflects the indispensable role of lamination films in modern packaging ecosystems across food,…
Global Curcumin Market Outlook 2031: Natural Antioxidant Demand, Regional Growth …
The global curcumin market is entering a structurally strong growth phase, underpinned by rising consumer preference for natural, plant-based ingredients and increasing clinical validation of curcumin's antioxidant and anti-inflammatory properties. As consumers shift away from synthetic additives and chemical-based therapeutics, curcumin is emerging as a high-value bioactive ingredient across , functional foods, cosmetics, and pharmaceuticals. Premiumization trends in organic products, combined with regulatory validation from food safety authorities, are expected…
Hemoglobin A1c Testing Devices Market to be Worth More Than USD 3.3 Bn by 2034 - …
The global Hemoglobin A1c (HbA1c) Testing Devices Market was valued at US$ 1.4 Bn in 2023 and is projected to expand at a CAGR of 7.7% from 2024 to 2034, reaching more than US$ 3.3 Bn by the end of 2034. The market growth is primarily attributed to the increasing global burden of diabetes, growing awareness about disease management, and technological advancements in diagnostic devices.
Get a concise overview of key…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
